HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of N-PEP-12 on memory among older adults.

Abstract
N-PEP-12 is a derivative of cerebrolysin, a brain-derived neuropeptide compound that has been approved for the treatment of Alzheimer's disease (AD) in more than 30 countries. N-PEP-12 is much less potent than cerebrolysin but it can be administered orally whereas the parent compound must be administered through multiple intravenous infusions. This study was undertaken to determine whether N-PEP-12 is effective in improving memory and other cognitive abilities among healthy older adults who have experienced 'normal' age-related memory loss. Subjects were 54 males and females, aged 50 years and older, who presented both subjective and objective evidence of memory loss since early adulthood. The study was a fully randomized, double-blind comparison of N-PEP-12 and placebo. Cognitive assessments were performed at baseline and following 30 days of treatment. The primary outcome measure was the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-cog) Memory score, with the Syndrom Kurz Test (SKT) test, digit cancellation, digit span, verbal fluency and clinical ratings as secondary outcomes. N-PEP-12 treated subjects performed better than placebo-treated subjects on the ADAS-cog Memory score, the SKT, clinical ratings and some, but not other tests. N-PEP-12 may be an effective treatment for memory loss in healthy older adults.
AuthorsThomas H Crook, Steven H Ferris, X Anton Alvarez, Martha Laredo, Herbert Moessler
JournalInternational clinical psychopharmacology (Int Clin Psychopharmacol) Vol. 20 Issue 2 Pg. 97-100 (Mar 2005) ISSN: 0268-1315 [Print] England
PMID15729085 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Amino Acids
  • N-PEP-12
  • Nootropic Agents
Topics
  • Aged
  • Amino Acids (therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Memory (drug effects)
  • Memory Disorders (drug therapy, psychology)
  • Middle Aged
  • Nootropic Agents (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: